Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Clinical Trials: Depression
A listing of clinical trials currently looking for volunteers to enroll in Depression studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Birmingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Birmingham : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Birmingham :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
View More »
Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Birmingham : Birmingham Research Group
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Birmingham : US009
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Birmingham : UAB
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
Birmingham : Forest Investigative Site 036
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Birmingham : Forest Investigative Site 021
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Birmingham : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Dothan : Harmonex
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Dothan : Dothan Behavioral Medicine Clinic
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Dothan : Harmonex
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Dothan : Dothan Behavioral Medicine Clinic
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Dothan : Forest Investigative Site 016
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Arizona
Tucson : Radiant Research - Tucson
New Clinical Research Study for Depression
View More »
Phoenix : Dedicated Clinical Research
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Phoenix : Dedicated Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Scottsdale : ResearchOne, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tucson : University of Arizona Clinical and Translational Science Center (CATS)
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Tucson : University of Arizona College of Medicine Department of Psychiatry
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Tucson : Genova Clinical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Tucson : University of Arizona Clinical and Translational Science Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Tucson : University of Arizona College of Medicine Department of Psychiatry
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Tucson : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Tucson : Forest Investigative Site 032 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Tucson :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Tucson :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Arkansas
Fayetteville : Forest Investigative Site 027
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Little Rock : Forest Investigative Site 029 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Little Rock : Forest Investigative Site 018 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
View More »
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Little Rock : K&S Professional Research Services, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
California
Arcadia : Pacific Clinical Research Medical Group
Depressed? Not Happy With Your Antidepressant?
Arcadia : Pacific Clinical Research Medical Group
Depressed? Sad? Unmotivated?
Cerritos : Comprehensive Clinical Development - Cerritos, CA
Depression ITN# 11336
Colton : SHANTI Clinical Trials
Depression
Encino : Pharmacology Research Institute, Encino
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder
Encino : Pharmacology Research Institute, Encino
Studies with investigational antidepressant medications for men and women 18 years and older.
Imperial : Sun Valley Research Center
Have you been diagnosed with Depression and your current medication is not working as it should?
Imperial : Sun Valley Research Center
Patients with Major Depressive Disorder
Los Alamitos : Pharmacology Research Institute, Los Alamitos
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder
Los Alamitos : Pharmacology Research Institute, Los Alamitos
Outpatient study for an investigation medication for depression
Los Alamitos : Pharmacology Research Institute, Los Alamitos
Studies with investigational antidepressant medications for men and women 18 years and older.
Newport Beach : Pharmacology Research Institute, Newport Beach
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder
Newport Beach : Pharmacology Research Institute, Newport Beach
Studies with investigational antidepressant medications for men and women 18 years and older.
Orange : Pacific Clinical Research Medical Group
Being a Kid is Hard Enough without having to deal with DEPRESSION
Orange : Pacific Clinical Research Medical Group
Depressed? Clinical Research Trial for Depression Now Enrolling in Orange, CA.
Sherman Oaks : California Neuroscience Research Medical Group, Inc.
Clinical research study of an investigational medication for Major Depressive Disorder.
Sherman Oaks : Schuster Medical Research Institute
Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder
Sherman Oaks : Schuster Medical Research Institute
Do you suffer from Bipolar Depression?
Sherman Oaks : Schuster Medical Research Institute
Research study of an investigational medication for Major Depression Disorder with partial response to antidepressants SSRI
Sherman Oaks, : California Neuroscience Research Medical Group, Inc.
Clinical research study of an investigational medication vs. placebo added to a
standard antidepressant treatment in persons with Major Depression.
Upland : Pacific Clinical Research Medical Group
Depressed?
Upland : Pacific Clinical Research Medical Group, Upland CA
Depressed? Sad? Clinical Trial for Depression Now Enrolling in Upland, CA
Upland : Pacific Clinical Research Medical Group
Depressed? Clinical Research Trial for Depression Now Enrolling in Upland, CA
Wildomar : Elite Clinical Trials, Inc.
Are you depressed? Do you feel like you just can't get beyond your depression?
View More »
Anaheim :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Anaheim : South Coast Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Anaheim : South Coast Medical Associates/SC Clinical Trials, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Arcadia : Pacific Clinical Research Medical Group
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Arcadia : US010
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Arcadia : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Arcadia : Forest Investigative Site 050 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Arcadia : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Beverly Hills : Southwest Research, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Beverly Hills : Forest Investigative Site 030
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Beverly Hills : Forest Investigative Site 009
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Beverly Hills : Forest Investigative Site 030
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Beverly Hills : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Carson : AV Institue, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Carson :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Cerritos :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Cerritos : Forest Investigative Site 029
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Cerritos : Forest Investigative Site 018
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Cerritos : Comprehensive NeuroScience
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Chino :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Chino : Catalina Research Institute, Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Chino : Catalina Research Institute, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Chino : Forest Investigative Site 012
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Chino : Stephen M. Mohaupt, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Colton : Shanti Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Costa Mesa : ATP Clinical Research, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Costa Mesa : ATP Clinical Research, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Costa Mesa : ATP Clinical Research, Inc.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Costa Mesa : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Costa Mesa :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Costa Mesa :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Costa Mesa : Gustavo Alva, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Costa Mesa : Forest Investigative Site 022
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Costa Mesa : Forest Investigative Site 002
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Costa Mesa : Forest Investigative Site 028
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Costa Mesa : Clinical Innovation, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Costa Mesa : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Downey : Diligent Clinical Trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Downey : Elizabeth Zarate-Rowell, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Encino :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Encino : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Encino : Forest Investigative Site 003
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Escondido : Synergy Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Escondido :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Escondido : Synergy Clinical Reserach Center of Escondido
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Garden Grove : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Garden Grove :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Garden Grove :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Garden Grove : Collaborative Neuroscience Network, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Garden Grove : Forest Investigative Site 077 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Garden Grove : Call for Information (Investigational Site 0042)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Garden Grove : Collaborative Neuroscience Network, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Glendale : Behavioral Research Specialists, LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Glendale : Behavioral Research Specialists, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Glendale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Glendale : Behavioral Research Specialists, Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Glendale :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Glendale : Behavioral Research Specialists, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Glendale : California Clinical Trials
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Glendale : Clinical Site
Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
Glendale : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Imperial : Sun Valley Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Imperial : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Imperial :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Imperial : Sun Valley Behavioral Medical
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Irvine : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Irvine :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Irvine : University of California, Irvine Child Development Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Irvine : Irvine Center for Clinical Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
La Habra : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
La Habra : Omega Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lond Beach : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Long Beach : Veterans Affairs Long Beach Healthcare System
Vilazodone for the Treatment of Posttraumatic Stress Disorder
Los Alamitos : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Los Angeles :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Los Angeles : Forest Investigative Site 017
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Los Angeles : Andrew F. Leuchter, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Los Angeles : UCLA Depression Research & Clinic Program
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Los Angeles : UCLA Semel Institute
Vilazodone for Treatment of Geriatric Depression
Mission Viejo : A.D.D. Treatment Center
International Study to Predict Optimised Treatment - in Depression
Murrieta : Forest Investigative Site 019
Safety and Efficacy of Vilazodone in Major Depressive Disorder
National City : Synergy Clinical Research Center
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
National City : Synergy Clinical Research Center
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
National City : Synergy Clinical Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
National City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
National City : US001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
National City : Forest Investigative Site 019 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
New port Beach : Forest Investigative Site 010
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Newport Beach : Forest Investigative Site 022 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Newport Beach :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Newport Beach : Pharmacology Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Newport Beach : Forest Investigative Site 005
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Norwalk : South Coast Clinicals
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Norwalk :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oakland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Oakland :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Oakland : Pacific Research Partners, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oakland :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oceanside : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Oceanside : Forest Investigative Site 004 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Oceanside :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Oceanside : North County Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oceanside :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Oceanside : Forest Investigative Site 039 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Oceanside : Forest Investigative Site 025
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Oceanside : Forest Investigative Site 015
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Oceanside : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Oceanside : North County Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Orange : Pacific Clinical Research Medical Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Orange : Pacific Clinical Research Medical Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orange : Pacific Clinical Research Medical Group
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orange :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Orange : US007
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Orange : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orange : Forest Investigative Site 043
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Palo Alto :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Palo Alto : Stanford -VA Palo Alto Health Care System
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Palo Alto : Stanford -VA Palo Alto Health Care System
Major Depressive Disorder With Mixed Features - Extension
Paramount :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Paramount :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Pasadena : Pasadena Research Institute, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Pico Rivera : CNRI Los Angeles LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Redlands :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Redlands : Anderson Clinical Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Redlands : Anderson Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Redlands : Anderson Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Redlands : Forest Investigative Site 008 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Redlands : Call for Information (Investigational Site 0027)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Redlands : Forest Investigative Site 003
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Riverside : Forest Investigative Site 027
Safety and Efficacy of Vilazodone in Major Depressive Disorder
San Bernardino : South Coast Clinical Trials, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Bernardino :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
San Diego : South Bay Research Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Diego : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
San Diego : Forest Investigative Site 007 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
San Diego : Forest Investigative Site 054 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
San Diego :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
San Diego :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
San Diego : Affiliated Research Institute
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Artemis Institute For Clinical Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Sharp Mesa Vista Hospital
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Affiliated Research Institute
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Clinical Innovations, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Sharp Mesa Vista Hospital
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Affiliated Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Pacific Research Network
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Artemis Institute For Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : California Neuropsychopharmacology Clinical
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego : Sharp Mesa Vista Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Diego :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
San Diego : Forest Investigative Site 022
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
San Diego : Ildiko Kovacs, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : PCSD - Feighner Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Diego : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
San Diego : CNRI-San Diego LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
San Diego : UCSD Medical Center
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
San Francisco : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Santa Ana : Neuropsychiatric Research Center of Orange County
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Santa Ana : Clinical Innovations, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Santa Ana : Neuropsychiatric Research Center of Orange County
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Santa Ana : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Santa Ana : Neuropsychiatric Research Center Of Orange County
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Santa Ana :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Santa Ana : Neuropsychiatric Research Center Of Orange County
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Santa Ana :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Santa Ana : Forest Investigative Site 015 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Santa Ana : Neuropsychiatric Research Center of Orange County
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Santa Ana : Clinical Innovations Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Sherman Oaks : California Neuroscience Research Medical Group, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Sherman Oaks : Schuster Medical Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Sherman Oaks : Forest Investigative Site 066 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Sherman Oaks : Forest Investigative Site 046
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Sherman Oaks : Thomas M. Shiovitz, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sherman Oaks : Schuster Medical Research Institute
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sherman Oaks : Schuster Medical Research Institute
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Stanford : Stanford University
International Study to Predict Optimised Treatment - in Depression
Stanford : Veteran Affairs/Stanford University
International Study to Predict Optimised Treatment - in Depression
Stanford : Stanford University Medical Center
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Tarzana : Center for Healing the Human Spirit
International Study to Predict Optimised Treatment - in Depression
Temecula : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Temecula : Forest Investigative Site 031 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Temecula : Forest Investigative Site 011
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Temecula : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Temecula : Viking Clinical Research Center
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Torrance :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Torrance : US004
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Torrance : UCLA-Harbor
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Torrence : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Upland : Pacific Clinical Research Medical Group
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Upland : Pacific Clinical Research Medical Group
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Upland : Forest Investigative Site 057
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Wildomar : Elite Clinical Trials, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Wildomar : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Wildomar : Elite Clinical Trials, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Wildomar :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Wildomar :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Colorado
Denver : Radiant Research - Denver
Clinical Research for Depression
Denver : Radiant Research - Denver
Research Study for Depression
Denver : Radiant Research - Denver
Still Depressed?
View More »
Aurora : Children's Hospital Colorado
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Aurora : The Children's Hospital
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Centennial : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Colorado Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Colorado Springs : MCB Clinical Research Centers
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Colorado Springs :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Denver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Denver : Radiant Research, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Denver : Forest Investigative Site 048 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Denver : Western Affiliated Research Institute
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Denver : Radiant Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Denver : Western Affiliated Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Denver : Western Affiliated Research Institute
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Connecticut
Hartford : Hartford Hospital - Institute of Living
Experiencing Depression Symptoms?
Hartford : Hartford Hospital - Institute of Living
The purpose of this research study is to evaluate the efficacy (how well the drug works), safety (the side effects), and tolerability (how well tolerated) of vilazodone compared to placebo (an inactive substance or sugar pill) in patients with depression.
Waterbury : Chase Medical Research, LLC
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
View More »
Cromwell : Connecticut Clinical Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cromwell : Connecticut Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cromwell : Forest Investigative Site 034
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Cromwell : Forest Investigative Site 016
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Cromwell : Connecticut Clinical Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Farmington : University of Connecticut Health Center
Study of Technology-assisted Treatment of Adolescent Depression
Hamden : Geriatric and Adult Psychiatry, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hartford : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Hartford : Institute of Living
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hartford : Hartford Hospital Institute of Living
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Middletown : Middlexex Hospital Center for Behavioral Health
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Britain : The Hospital of Central Connecticut, Psychiatry & Behavioral Health Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Haven : Yale Depression Research Program
Cortical GABA Concentrations in Subjects With Primary Insomnia and Depression in Partial Remission With Residual Insomnia
New Heaven : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Norwalk :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Norwalk :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Norwalk : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Norwich : Comprehensive Psychiatric Care
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Norwich :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Norwich : Comprehensive Psychiatric Care
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Delaware
Wilmington : Christiana Care Health Services
Patient-Centered Depression Care for African Americans
District of Columbia
Washington :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Washington :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Washington : US003
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Washington DC : Comprehensive NeuroScience
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Florida
Maitland : Florida Clinical Research Center - Orlando/Maitland
Are you Depressed?
Maitland : Florida Clinical Research Center - Orlando/Maitland
Depression getting you down?
Miami : Pharmax Research Clinic, Inc.
Depression Disorder
Pinellas Park : Radiant Research - St. Petersburg
Research Opportunity (Heat Patch)
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Depression ITN# 12040
View More »
Aventura : Scientific Clinical Research, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Boca Raton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Bradenton : Florida Clinical Research Center, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bradenton : Florida Clinical Research Center
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Brooksville : Meridien Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brooksville : Meridien Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clearwater : Innovative Research of West Florida, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Clearwater : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Coral Gables : Sanitas Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Coral Springs :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Coral Springs : CNS Clinical Research Group
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Coral Springs : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Destin : SJS Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Destin : SJS Clinical Research, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Doral : Forest Investigative Site 020
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Fort Myers : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Fort Myers : Gulfcoast Clinical Research Center
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Fort Myers : Forest Investigative Site 006
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Fort Myers : Forest Investigative Site 038
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Fort Myers : Gulfcoast Clinical Research Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Fort Walton Beach : Emerald Coast Mood & Memory, PA
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Ft. Lauderdale : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Ft. Lauderdale : Forest Investigative Site 007
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Gainesville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Gainesville : Sarkis Clinical Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Gainesville :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Gainesville : Sarkis Clinical Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gainsville : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Gainsville : Forest Investigative Site 018
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Hallandale Beach : Call for Information (Investigational Site 0036)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Hallandale Beach : Forest Investigative Site 055
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Hallandale Beach : Forest Investigative Site 004
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Hialeah : Amedica Research Institute, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Hialeah : Amedica Research Institute, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Hollywood : Segal Institute for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Jacksonville : Clinical Neuroscience Solutions, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Jacksonville : Clinical Neuroscience Solution, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Jacksonville : Clinical Neuroscience Solutions, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Jacksonville :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Jacksonville : Amit Vijapura
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jacksonville : Amit Vijapura
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jacksonville : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jacksonville : Forest Investigative Site 029 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Jacksonville : Forest Investigative Site 063
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Jacksonville : Forest Investigative Site 005
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Jacksonville : Forest Investigative Site 012
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Jacksonville : Amit Vijapura MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Jacksonville : Clinical Neuroscience Solutions, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Jacksonville : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Jacksonville : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Jacksonville : Clinical Neuroscience Solutions Inc
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Jacksonville Beach : Forest Investigative Site 008
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Jacksonville Beach : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Jacksonville Beach : George M. Joseph, MD & Associates, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Juno Beach : Advanced Mental Health Care Inc. - Juno Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Kissimmee : Accurate Clinical Trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Kissimmee : Forest Investigative Site 012 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Lake City : Forest Investigative Site 063 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Lake City : Psychiatric Associates
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lauderhill : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Lauderhill :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Lauderhill :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Lauderhill :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Lauderhill : Fidelity Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Lauderhill : Fidelity Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Leesburg : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Leesburg : Forest Investigative Site 006 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Leesburg : Compass Research, LLC: North Clinic
Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder
Leesburg : Forest Investigative Site 015
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Maitland : Florida Clinical Research Center
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Maitland : Florida Clinical Research Center, LLC.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Maitland : US006
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Melbourne : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Miami : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Miami : Forest Investigative Site 026 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Miami :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Miami :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Miami : US003
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Miami : University of Miami
International Study to Predict Optimised Treatment - in Depression
Miami : Miami Jewish Health System
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Miami : Forest Investigative Site 035
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Miami Springs : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
New Port Richey : Suncoast Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Bay Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
North Miami : Forest Investigative Site 027 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
North Miami :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
North Miami :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
North Miami : Scott Daniel Segal, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Miami : David H. Flaherty, DO
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Oakland Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Ocala :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Orange City :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Orlando : Ali A. Kashfi, MD
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Orlando : Clinical Neuroscience Solutions Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Orlando : Clinical Neuroscience Solutions, Inc
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Orlando : Ali A. Kashfi, MD
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orlando : Clinical Neuroscience Solutions Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Orlando : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Orlando :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Orlando : Compass Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Orlando : Clinical Neuroscience Solutions, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Orlando :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Orlando : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orlando : Compass Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Orlando : Forest Investigative Site 026 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Orlando : Forest Investigative Site 030
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Orlando : Forest Investigative Site 062
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Orlando : Forest Investigative Site 004
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Orlando : Forest Investigative Site 035
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Orlando : Ali A. Kashfi, MD, PA
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Orlando : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Orlando : Compass Research, LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pembroke Pines : Forest Investigative Site 045
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Plantation : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Sanford : Medical Research Group of Central Florida
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Sanford :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Sanford :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
South Miami : Forest Investigative Site 044 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
St Petersburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
St Petersburg : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
St Petersburg : Comprehensive Clinical Development, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
St. Petersburg : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
St. Petersburg : Comprehensive NeuroScience, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Petersburg : Meridien Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Petersburg :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Tampa : Stedman Clinical Trials
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Tampa :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Tampa : Stedman Clinical Trials
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tampa :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Tampa : Forest Investigative Site 051
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Tampa : University of South Florida
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Tampa : Stedman Clinical Trials, LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
University Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
West Palm Beach :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
West Palm Beach : Janus Center For Psychiatric Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
West Palm Beach : Janus Center for Psychiatric Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
West Palm Beach :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
West Palm Beach : Janus Center For Psychiatric Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
West Palm Beach : Forest Investigative Site 032
Safety and Efficacy of Vilazodone in Major Depressive Disorder
West Palm Beach : Forest Investigative Site 001
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Winter Haven : Clinical Research of Central Florida
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Winter Park : Kolin Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Winter Park : Kolin Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Winter Park : Winter Park Memorial Hospital
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Winter Park : Forest Investigative Site 019 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Winter Park : Forest Investigative Site 022
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Winter Park : Forest Investigative Site 013
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Winter Park : Kolin Research Group
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Winterpark : Winter Park Memorial Hospital
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Georgia
Atlanta : Mood and Anxiety Disorders Program of Emory University
Have you been feeling sad or down nearly every day over the past month?
Atlanta : Mood and Anxiety Disorders Program of Emory University
How are you feeling?
Stockbridge : Mood and Anxiety Disorders Program of Emory University
Have you been feeling sad or down nearly every day over the past month?
View More »
Atlanta : Atlanta Center for Medical Research
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Atlanta : Atlanta Center for Medical Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Atlanta : Atlanta Center for Medical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Atlanta : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Atlanta : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Atlanta : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Atlanta : Forest Investigative Site 024 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Atlanta :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Atlanta :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Atlanta : Emory University
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Atlanta : Atlanta Institute of Medicine & Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Atlanta : Comprehensive Neuroscience, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Atlanta : Emory University
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Atlanta :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Atlanta : Emory University
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Atlanta : Forest Investigative Site 062 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Atlanta : Forest Investigative Site 060
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Atlanta : Forest Investigative Site 012
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Atlanta : Forest Investigative Site 005
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Atlanta : Forest Investigative Site 038
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Atlanta : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Atlanta : Atlanta Center for Medical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Atlanta : Atlanta Center for Medical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Marietta : Northwest Behavioral Research Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Marietta : Northwest Behavioral Research Center/Northwest Behavioral Medicine
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Roswell :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Smyma : Forest Investigative Site 065 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Smyrna : Institute for Behavioral Medicine, LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Smyrna : Institute for Behavioral Medicine, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Smyrna :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Smyrna : Carman Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Smyrna : Carman Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Smyrna : Call for Information (Investigational Site 0028)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Smyrna : Institute for Behavioral Medicine, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Smyrna : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Smyrna : Carman Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Hawaii
Honolulu : Hawaii Clinical Research Center
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Do you suffer from Depression?
Chicago : Rush University Medical Center - Treatment Research Center
Preventing the Recurrence of Depression in Bipolar Disorder
Chicago : Chicago Research Center, Inc
This research will evaluate the safety, tolerability and efficacy of an experimental drug, Levomilnacipran, sustained release (SR) compared to placebo (inactive substance) in the potential treatment of depression in people with Major Depressive Disorder.
Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.
Depression Research Study
Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.
Depression Research Study for adults who are currently taking an antidepressant but still experiencing some symptoms of depression
Skokie : Rush University Medical Center - Treatment Research Center
Depression Study. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
View More »
Chicago :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Chicago :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Chicago : Richard S. Abrams, MD- Psychiatry
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)
Chicago : Colette Bostin-Gordon, MD
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)
Chicago : Rush Medical College
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Chicago : Call for Information (Investigational Site 0029)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Chicago : Forest Investigative Site 037
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Chicago : Forest Investigative Site 050
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Chicago : Forest Investigative Site 029
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Chicago : Corey N. Goldstein, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chicago : TMS Specialists Chicago
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Hoffman Estates : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Hoffman Estates : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Hoffman Estates : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Hoffman Estates : Forest Investigative Site 013 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Hoffman Estates :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Hoffman Estates : Forest Investigative Site 019
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Hoffman Estates : Alexian Brothers Center for Psychiatric Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Joliet : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Joliet :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Libertyville : Capstone Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Libertyville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Libertyville : Capstone Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Naperville : AMR-Baber Research Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Naperville : AMR Baber Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Naperville : AMR-Baber Research Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Naperville :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oak Brook : American Medical Research, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oak Brook :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oak Brook :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Oakbrook Terrace : Midwest Center for Neurobehavioral Medicine
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Park Ridge : CNS - Comprehensive Neuro Science
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Skokie : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Skokie :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Skokie : Psychiatric Medicine Associates, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Stokie : Psychiatric Medicine Associates
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Vernon Hills : Sleep and Behavior Medicine Institute
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Indiana
Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Indianapolis : The Davis Clinic
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Indianapolis :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Indianapolis : Forest Investigative Site 040
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Indianapolis : Forest Investigative Site 021
Safety and Efficacy of Vilazodone in Major Depressive Disorder
View More »
Indianapolis : Forest Investigative Site 024
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Indianapolis : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Lafayette : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Lafayette : Forest Investigative Site 042 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Lafayette : Alpine Clinic
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lafayette : Forest Investigative Site 012
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Lafayette : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Lafayette : Alpine Clinic
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Newburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Newburgh : Pedia Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Terre Haute : Clinco
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Terre Haute : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Terre Haute : Clinco
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Terre Haute : Clinco
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Terre Haute : Clinco
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Valparaiso : Northwest Indiana Center for Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kansas
Overland Park : Psychiatric Associates
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Overland Park : Psychiatric Associates
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Prairie Village :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
View More »
Prairie Village :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Prairie Village : Clinical Trials Technology, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Prairie Village : Forest Investigative Site 074 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Prairie Village : Call for Information (Investigational Site 0041)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Prairie Village : Forest Investigative Site 053
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Prairie Village : Forest Investigative Site 031
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Prairie Village : Clinical Trials Technology, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Prairie Village : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Wichita : Heartland Research Associates, LLC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Wichita :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Wichita : Heartland Research Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wichita : US004
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Wichita : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Kentucky
Edgewood : OtriMed Clinical Research
Adult Major Depressive Disorder Clinical Trial
Lexington : Kentucky Medical Research
Depression
View More »
Crestview Hills : Community Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Florence : MCM Clinical Research LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lexington : Central Kentucky Research Associates, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Lexington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Owensboro : Pedia Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Louisiana
Lake Charles : Lake Charles Clinical Trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Lake Charles : Lake Charles Clinical Trials
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Lake Charles : Lake Charles Clinical Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Lake Charles : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Lake Charles :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
View More »
New Orleans : James G. Barbee, Md, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
New Orleans : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Shreveport : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Shreveport :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Shreveport : J. Gary Booker, Md, Apmc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Shreveport :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Shreveport : Louisiana Clinical Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Shreveport :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Shreveport : J. Gary Booker, Md, Apmc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Shreveport :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Maryland
Gaithersburg : Potomac Grove Clinical Research Center
An Investigational Medication for Major Depressive Disorder
Gaithersburg : Potomac Grove Clinical Research Center
Major Depressive Disorder and Sexual Dysfunction
View More »
Baltimore : Pharmasite Research Inc
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Baltimore : Pharmasite Research Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Baltimore : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Baltimore : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Baltimore :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Baltimore : Pharmasite Research, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Baltimore :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Baltimore : Johns Hopkins University
Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
Baltimore : Johns Hopkins School of Medicine
Patient-Centered Depression Care for African Americans
Baltimore : Sinai Hospital
Patient-Centered Depression Care for African Americans
Baltimore : Baltimore Medical Systems, Middlesex Health Center
Patient-Centered Depression Care for African Americans
Baltimore : Johns Hopkins Community Phsyicians
Patient-Centered Depression Care for African Americans
Baltimore : Sheppard Pratt Health System
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Baltimore : Call for Information (Investigational Site 0033)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Baltimore : Forest Investigative Site 020
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Baltimore : Johns Hopkins University
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Baltimore : Forest Investigative Site 001
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Baltimore : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Baltimore : Sheppard Pratt Health System
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Gaithersburg : Forest Investigative Site 049 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Gaithersburg :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Gaithersburg : Potomac Grove Clinical Research Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Glen Burnie : Clinical Insights
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Rockville : Neuroscientific Insights
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Rockville : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Rockville : Office of Marc Hertzman, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Towson : Forest Investigative Site 001
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Massachusetts
Brighton : Boston Clinical Trials
Do you often feel sad, down and unmotivated?
Have you been taking medication for depression but still have symptoms?
Brighton : Boston Clinical Trials
I Feel Blue…
Brighton : Boston Clinical Trials
Stuck with Depression? You are not alone.
Haverhill : ActivMed Practices & Research, Inc.
Are you between the ages of 18 and 65 and suffering from Depression?
Haverhill : ActivMed Practices & Research, Inc.
Are you or a loved one suffering from symptoms of Bipolar Disorder?
Haverhill : ActivMed Practices & Research, Inc.
Has your depression got you feeling down? Are you having trouble concentrating on your tasks?
Haverhill : ActivMed Practices & Research, Inc.
Has your depression got you feeling down? Are you having trouble concentrating on your tasks?
View More »
Belmont : Mclean Hospital
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Belmont : McLean Hospital - McLean Imaging Center
Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder
Belmont : McLean Hospital
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder (MDD) Partly Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Treatment
Belmont : Mclean Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Belmont : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Boston : Boston Clinical Trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Boston : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Boston : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Boston : Forest Investigative Site 046 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Boston :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Boston : Massachusetts General Hospital
Escitalopram (Lexapro) for the Treatment of Postpartum Depression
Boston : Massachusetts General Hospital
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
Major Depressive Disorder With Mixed Features - Extension
Boston : Forest Investigative Site 031
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Boston : Forest Investigative Site 003
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Boston : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Boston : Massachusetts General Hospital- Depression Clinical and Research Program
Transcranial Laser Therapy for Major Depressive Disorder
Cambridge : Cambridge Health Alliance
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Cambridge : Cambridge Health Alliance
Ropinirole in the Treatment of Bipolar Depression
Chelsea : Chelsea Counseling Center- North Suffolk Mental Health Association
Transcranial Laser Therapy for Major Depressive Disorder
Fall River : AccelRx Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Fall River : AccelRx Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Haverhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Haverhill : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Haverhill :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Haverhill : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Watertown : Adams Clinical Trials, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Watertown : Adams Clinical Trials LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Weymouth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Weymouth :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Weymouth : Forest Investigative Site 013
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Weymouth : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Woburn : Woburn Pediatric Associates
Study of Technology-assisted Treatment of Adolescent Depression
Michigan
Ann Arbor : Michigan Head Pain and Neurological Institute
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Rochester Hills : Forest Investigative Site 028
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Rochester Hills : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Minnesota
Rochester : Mayo College of Medicine
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Mississippi
Flowood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Flowood :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Flowood :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Flowood :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Flowood : Forest Investigative Site 040 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
View More »
Flowood : Precise Research Centers
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Missouri
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Are you down in the dumps with your diabetes?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Depression Research Study Seeks Volunteers with Heart Failure.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Pre-diabetes: Are you at risk?
View More »
Creve Coeur : Millennium Psychiatric Associates, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Creve Coeur : Millennium Psychiatric Associates, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Creve Coeur :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Creve Coeur : Forest Investigative Site 068 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Creve Coeur : Forest Investigative Site 026
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Creve Coeur : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Gladstone : Asim Ulusarac, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Kansas City : The Center for Pharmaceutical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
O'Fallon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
O'Fallon : Howard J. Ilivicky, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
St Louis :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
St. Charles : St. Charles Psychiatric Associates - Midwest Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
St. Charles : St Charles Psychiatric Associates
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
St. Charles : Midwest Chest Consultants
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
St. Charles : St. Charles Psychiatric Associates - Midwest Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
St. Charles : St. Charles Psychiatric Associates - Midwest Research Group
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Louis : Scientella LLC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
St. Louis : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
St. Louis :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
St. Louis : Mercy Health Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Louis :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
St. Louis : St. Louis Clinical Trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
St. Louis : Mid-America Clinical Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
St. Louis : Washington University School of Medicine
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Nebraska
Lincoln : Premier Psychiatric Research Institute, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Lincoln : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Lincoln : Premier Psychiatric Research Institute, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Lincoln : Premier Psychiatric Research Institute, LLC.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
North Platte : Heartland Pharma Development
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
View More »
North Platte :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Omaha : Quality Clinical Research, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Omaha : Creighton University, Department of Psychiatry
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Omaha : University of Nebraska Medical Center
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Nevada
Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Las Vegas :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
View More »
Las Vegas : Forest Investigative Site 037
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Las Vegas : Clinical Research Consortium
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Hampshire
New Jersey
Cherry Hill : Center For Emotional Fitness
DEPRESSION
Cherry Hill : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Mount Laurel : CRI Lifetree
Do you or a loved one suffer from Depression?
New Brunswick : UMDNJ-Robert Wood Johnson Medical School
Coping With Depression in Parkinson's Disease
View More »
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Berlin : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Cherry Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Cherry Hill :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Cherry Hill : Forest Investigative Site 061 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Cherry Hill : Forest Investigative Site 023
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Cherry Hill : Center for Emotional Fitness
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cherry Hill : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Cherry Hill : Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Marlton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Marlton : CRI Lifetree
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Mount Laurel : CRI Worldwide, LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Princeton : Global Medical Institutes
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Princeton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Toms River :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Toms River : Bio Behavioral Health
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toms River : Bio Behavioral Health
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toms River : Bio Behavioral Health
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toms River : Call for Information (Investigational Site 0035)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Voorhees : Amita Talati- MD
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)
Willingboro : CRI Worldwide, LLC
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Willingboro :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Willingboro : Forest Investigative Site 038 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Willingboro : Forest Investigative Site 024
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Willingboro : Forest Investigative Site 014
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Willingboro : CRI Worldwide LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New Mexico
Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Albuquerque : Forest Investigative Site 058 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Albuquerque :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Albuquerque :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Albuquerque : Albuquerque Neuroscience, Inc.
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Albuquerque : Albuquerque Neuroscience, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Albuquerque : Forest Investigative Site 030 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Albuquerque : Forest Investigative Site 011
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Albuquerque : Forest Investigative Site 010
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Albuquerque : Forest Investigative Site 006
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Albuquerque : Glenn Michael Dempsey, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
New York
Bronx : Biomedical Research Alliance of New York
Major Depressive Disorder
New York : Clinilabs, Inc.
Are anti-depression medications just not working for you? (New York, NY)
New York : Medical & Behavioral Health Research, PC
Bipolar Depression
New York : Medical & Behavioral Health Research, PC
Bipolar Depression Research Study
New York : Medical & Behavioral Health Research, PC
Depressed?
New York : Medical & Behavioral Health Research, PC
DEPRESSED? 18-65 YEARS OLD?
New York : Clinilabs, Inc.
Feeling Depressed?
New York : Clinilabs, Inc.
Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?
New York : Clinilabs, Inc.
Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?
New York : Biomedical Research Alliance of New York
Major Depressive Disorder
View More »
Bronx : Montefiore Medical Center
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brooklyn : Social Psychiatry Research Institute
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Brooklyn : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Brooklyn : Forest Investigative Site 028 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Brooklyn : Brooklyn Medical Institute
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brooklyn : US014
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Brooklyn : Social Psychiatry Research Institute
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brooklyn :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Brooklyn : Forest Investigative Site 076 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Brooklyn : Forest Investigative Site 004
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Brooklyn : Forest Investigative Site 003
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Brooklyn : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Brooklyn : Behavioral Medical Research of Brooklyn
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Brooklyn : Behavioral Medical Research of Brooklyn
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cedarhurst :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Cedarhurst : Neurobehavioral Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cedarhurst :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Cedarhurst : Forest Investigative Site 007
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Fresh Meadows : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Fresh Meadows : Comprehensive Clinical Development, Inc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Fresh Meadows : Comprehensive Clinical Development, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Fresh Meadows : Comprehensive Clinical Development, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Fresh Meadows : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Glen Oaks : The Zucker Hillside Hospital
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Mount Kisco : Bioscience Research, LLC.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Mount Kisco : Bioscience Research, LLC.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Mount Kisco : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Mount Kisco : Bioscience Research, Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Mount Kisco : Bioscience Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Mount Kisco : Forest Investigative Site 037 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Mt. Kisco : Bioscience Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
New York : Mount Sinai School of Medicine
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
New York : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
New York : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
New York : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
New York : Forest Investigative Site 016 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
New York :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
New York : New York State Psychiatric Institute/Columbus Circle Midtown
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
New York : Depression Evaluation Service (DES), New York State Psychiatric Institute, Columbia University Department of Psychiatry
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
New York : Village Clinical Research, Inc.
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
New York :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
New York : Medical & Behavioral Health Research, PC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Fieve Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
New York : US011
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
New York : US013
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
New York : Weill Medical College of Cornell University
Lexapro for Major Depression in Patients With Epilepsy
New York : Village Clinical Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
New York : New York State Psychiatric Institute, 1051 Riverside Drive
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
New York : Weill Cornell Medical College
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
New York : Jan Roda, MD - Psychiatry
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AT1)
New York : Forest Investigative Site 067 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
New York : Call for Information (Investigational Site 0039)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
New York : Forest Investigative Site 047
Safety and Efficacy of Vilazodone in Major Depressive Disorder
New York : Mount Sinai Hospital
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
New York : Forest Investigative Site 025
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
New York : Clinlabs, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Daniel V. Iosifescu, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
New York : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
New York : Medical and Behavioral Health Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
New York : Fieve Clinical Services, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
New York : Medical and Behavioral Health Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
New York : Mount Sinai School of Medicine
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
New York City : Forest Investigative Site 058
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Rochester : Finger Lakes Clinical Research
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Rochester : Finger Lakes Clinical Research
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Rochester : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Rochester :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Rochester :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Rochester : Finger Lakes Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Staten Island : Behavioral Medical Research of Staten Island
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Staten Island : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Staten Island :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Staten Island : Richmond Behavioral Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Staten Island :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Staten Island : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Staten Island : Richmond Behavioral Associates
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Staten Island : Behavioral Medical Research of Staten Island
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Staten Island : Richmond Behavioral Associates
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Staten Island : Behavioral Medical Research of Staten Island
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Stony Brook : Stony Brook University Medical Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Stony Brook : Stony Brook University Medical Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Syracuse : Suny Upstate Medical University
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
West Seneca : Daniel I. Rifkin MD PC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
White Plains : Weill Cornell Medical College
International Study to Predict Optimised Treatment - in Depression
White Plains : Weill Cornell Medical College-Westchester Division
Treatment Response of Geriatric Depression
North Carolina
Charlotte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Charlotte : Carolinas Healthcare System
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Charlotte : Carolinas Healthcare System
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Durham : Triangle Neuropsychiatry
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Durham : Psychiatry and Behavioral Sciences, Duke
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
View More »
Durham : Psychiatry and Behavioral Sciences, Duke
Major Depressive Disorder With Mixed Features - Extension
Durham : Forest Investigative Site 014
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Durham : Forest Investigative Site 004
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Durham : Duke University Brain Stimulation and Neurophysiology Center
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Greensboro : Call for Information (Investigational Site 0034)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Hickory : James Barker, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Raleigh :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Raleigh : Rcihard H. Weisler, MD, PA & Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Raleigh : Richard H. Weisler, Md, Pa & Assoc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Raleigh : Call for Information (Investigational Site 0052)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Raleigh : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Wilmington : PMG Research of Wilmington
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Winston-salem : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Ohio
Cincinnati : Community Research
Feeling Depressed?
Cincinnati : Community Research
Not seeing the results you want from your antidepressant?
View More »
Avon lake :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Beachwood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Beachwood : Northcoast Clinical Trials, Inc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Beachwood :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Beachwood : Northcoast Clinical Trials, Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Beachwood : Call for Information (Investigational Site 9089)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Beachwood : Bijan Bastani, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Beachwood : North Coast Clinical Trials, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Canton : Neuro-Behvioral Clinical Research, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Canton : Neuro-Behavioral Clinical Research, Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Canton : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Canton : Forest Investigative Site 047 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Canton : Forest Investigative Site 036
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Canton : Neuro-Behavioral Clinical Research, Inc
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cincinatti :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Cincinatti : Community Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Cincinnati : Community Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Cincinnati : University of Cincinnati
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Cincinnati : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Cincinnati : Patient Priority Clinical Sites, Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cincinnati : Patient Priority Clinical Sites, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Cincinnati : Forest Investigative Site 039
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Cincinnati : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Cincinnati : University of Cincinnati
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Cincinnatti : US002
Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder
Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Cleveland : University Hospitals Case Medical Center
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Columbus : Radiant Research, Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Columbus : Ohio State University
International Study to Predict Optimised Treatment - in Depression
Columbus : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Dayton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dayton : Midwest Clinical Research Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Dayton : Midwest Clinical Research Center
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Dayton : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Dayton :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Dayton :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Dayton : Bernadette B. D'Souza, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dayton : Midwest Clinical Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Dayton : Forest Investigative Site 021 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Dayton : Forest Investigative Site 002
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Dayton : Forest Investigative Site 008
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Dayton : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Garfield Heights :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Mason : Lindner Center of HOPE
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Mason : Lindner Center of HOPE
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Mason : Lindner Center of HOP
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Middleburg Heights : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Middleburg Heights : North Star Medical Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Middleburg Heights : North Star Medical Research, LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toledo : Neurology and Neuroscience Center of Ohio
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Toledo :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Toledo : Neurology & Neuroscience Center Of Ohio
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toledo :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Toledo : Neurology & Neuroscience Center Of Ohio
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toledo : Neurology & Neuroscience Center of Ohio
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toledo : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Toledo : Kettlie Joseph Daniels, MD
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Oklahoma
Enid : Cutting Edge Research of Enid
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Oklahoma City : Cutting Edge Research Group
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Oklahoma City : IPS Research Company
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Oklahoma City : SP Research, PLLC
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
View More »
Oklahoma City : Cutting Edge Research of Enid
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Oklahoma City : IPS Research Company
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Oklahoma City : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Oklahoma City :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Oklahoma City : SP Research, PLLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City : Sooner Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Oklahoma City : Ips Research Company
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Oklahoma City : Forest Investigative Site 042
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Oklahoma City : Forest Investigative Site 048
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Oklahoma City : Forest Investigative Site 024
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Oklahoma City : Forest Investigative Site 025
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Oklahoma City : IPS Research Company
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oklahoma City : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Oklahoma City : Lynn Health Science Institute
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Oklahoma City : Sooner Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Oklahoma City : IPS Research Company
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Tulsa : Tulsa Clinical Research, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Oregon
Portland : Summit Research Network (Oregon), Inc.
Depression Research Study
View More »
Medford : Sunstone Medical Research, LLC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Portland : Summit Research Network (Oregon), Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Portland : Summit Research Network (Oregon), Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Portland : Oregon Health & Science University
Circadian Effects of Escitalopram
Portland :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Portland :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Portland : Summit Research Network (Oregon) Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Portland : US012
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Portland : Summit Research Network (Oregon) Inc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Portland : Forest Investigative Site 022 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Portland : Call for Information (Investigational Site 0040)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Portland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Portland : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Portland : Oregon Center for Clinical Investigators, Inc. (OCCI, Inc.)
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc)
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Salem : Forest Investigative Site 027 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Salem : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Pennsylvania
Media : Suburban Research Associates
Do you suffer from Depression & Pain?
View More »
Allentown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Allentown : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Allentown : Lehigh Center for Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Allentown :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Allentown :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Allentown : Lehigh Center for Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Allentown :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Allentown : Forest Investigative Site 014
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Allentown : Forest Investigative Site 009
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Allentown : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Allentown : Lehigh Center for Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Allentown : Lehigh Center for Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Bala Cynwyd : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Bridgeville : Paramount Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Broomall : Southeastern PA Medical Institute
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Jenkintown :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Media : Suburban Research Associates
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Media : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Media : Suburban Research Associates
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Media :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Media : Shivkumar Hatti, MD, MBA
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Media : Suburban Research Associates
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Media : Forest Investigative Site 010
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Norristown : Keystone Clinical Studies, Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Norristown :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Norristown : Keystone Clinical Studies, Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Norristown : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Philadelphia : CRI Worldwide
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Philadelphia : University of Pennsylvania
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Philadelphia : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Philadelphia :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Philadelphia : CRI Worldwide LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Philadelphia : Thomas Jefferson University
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Philadelphia : University Of Pennsylvania
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Philadelphia :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Philadelphia : CRI Lifetree- Philadelphia Research Center
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Philadelphia : Forest Investigative Site 025 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Philadelphia : Forest Investigative Site 011
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Philadelphia : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Philadelphia : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Philadelphia : Belmont Center for Comprehensive Treatment
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Philadelphia : University of Pennsylvania
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Pittsburgh : University of Pittsburgh School of Medicine
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Pittsburgh :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Pittsburgh : Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Scranton : Scranton Counseling Center
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
West Chester : University Services
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wyomissing : Behavioral Medicine Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Wyomissing : Clinical Research Center of Reading, LLP
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Rhode Island
Lincoln : Lincoln Research - Rhode Island
Announcing a medical research study for adults with DEPRESSION and FATIGUE?
Lincoln : Lincoln Research - Rhode Island
depressed...? Approximately one in 10 people suffer from depression...you are not alone.
Lincoln : Lincoln Research - Rhode Island
Do you feel Depressed? Announcing a medical research study for people with depression.
Lincoln : Lincoln Research - Rhode Island
Is the burden of Depression weighing you down...despite medication?
Lincoln : Lincoln Research - Rhode Island
Suffering from bipolar depression and are depressed and on medication?
View More »
East Greenwich : Costal Medical
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
East Providence : Rhode Island Mood & Memory Research Institute
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lincoln : Lincoln Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lincoln :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Lincoln : Lincoln Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Lincoln : Call for Information (Investigational Site 0044)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Lincoln : Forest Investigative Site 015
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Lincoln : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Providence : Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Warwick : Omega Medical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
South Carolina
Greer : Radiant Research - Greer
Clinical Research Study for Depression
Mt. Pleasant : Coastal Carolina Research Center
Volunteers who suffer from Fibromyalgia pain and also Depression are needed for a new clinical research study.
View More »
Charleston : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Charleston : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Charleston : MUSC Institute of Psychiatry, Brain Stimulation Lab
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Columbia :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Columbia :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Columbia : Carolina Clinical Research Services
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Columbia : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Greer : Radiant Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Mount Pleasant : Coastal Carolina Research Center
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
North Charleston : Medical University South Carolina Anxiety Disorder Program
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Tennessee
Memphis : Research Strategies of Memphis
To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder
Memphis : Research Strategies of Memphis, LLC
To evaluate safety and efficacy of add on therapy in treatment of Major Depression Disorder
Nashville : Clinical Research Associates
Major Depression
View More »
Franklin : Psychiatric Consultants, PC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Franklin :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Franklin : Psychiatric Consultants, Pc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Memphis : Research Strategies of Memphis, LLC
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Memphis : Clinical Neuroscience Solutions, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Memphis : Clinical NeuroScience Solutions, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Memphis : Clinical Neuroscience Solutions, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Memphis : Research Strategies of Memphis, LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Memphis :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Memphis : Clinical Neuroscience Solutions, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Memphis : Anita Sudan Varma, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Memphis : Clinical Neuroscience Solutions, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Memphis :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Memphis : Forest Investigative Site 048 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Memphis : Forest Investigative Site 064
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Memphis : Forest Investigative Site 008
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Memphis : Forest Investigative Site 019
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Memphis : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Memphis : Clinical Neuroscience Solutions, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nashville : Vanderbilt University Medical Center
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Nashville : Clinical Research Associates
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nashville : Centerstone
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Texas
Dallas : Research Across America
Major Depression
Houston : Bayou City Research Corporation
Still Depressed?
San Antonio : Croft Group Research Center
Are you DEPRESSED?
San Antonio : Croft Group Research Center
Are you taking an antidepressant but still depressed?
San Antonio : Radiant Research - San Antonio
Clinical Research for Depression
San Antonio : Croft Group Research Center
Have you had several depressive episodes?
San Antonio : Radiant Research - San Antonio
Research Study for Depression
View More »
Ausitn : Senior Adults Specialty Research
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Austin : FutureSearch Clinical Trials, L.P.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Austin : FutureSearch Trials of Neurology
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Austin : FutureSearch Clinical Trials, L.P.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Austin : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Austin :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Austin : Future Search Trials
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Austin : FutureSearch Clinical Trials, LP
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Austin : Community Clinical Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Austin : Forest Investigative Site 024 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Austin : Forest Investigative Site 013
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Austin : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Austin : FutureSearch Trials of Neurology
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Dallas : FutureSearch Trials of Dallas
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Dallas : Updated
A Study of Ketamine in Patients With Treatment-resistant Depression
Dallas : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Dallas : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Dallas :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Dallas :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Dallas : Futuresearch Trials Of Dallas
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Dallas : Future Search Trials of Dallas, LP
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas : KRK Medical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Dallas : Futuresearch Trials Of Dallas
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Dallas : Dept. of Psychiatry, UT Southwestern Medical Center
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Dallas : Dept. of Psychiatry, UT Southwestern Medical Center
Major Depressive Disorder With Mixed Features - Extension
Dallas : Forest Investigative Site 020 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Dallas : Forest Investigative Site 021
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Dallas : Forest Investigative Site 023
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Dallas : UT Southwestern Medical Center at Dallas
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
Dallas : Forest Investigative Site 007
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Dallas : Pillar Clinical Research, LLC
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Dallas : UT Southwestern Medical Center
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Desoto : Insite Clinical Research
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Desoto : Insite Clinical Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Desoto : Insite Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Friendswood : Bay Area Clinical Services
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Friendswood : Bay Area Clinical Services
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Houston : Claghorn-Lesem Research Clinic
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Houston : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Houston : Forest Investigative Site 005 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Houston :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Houston : Ben Taub General Hospital
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Claghorn-Lesem Research Clinic, Ltd.
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Houston :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Houston : Ben Taub General Hospital
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Red Oak Psychiatry Associates, Pa
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Ut Health-Houston
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Houston : Forest Investigative Site 070 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Houston : Call for Information (Investigational Site 0031)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
Houston : Forest Investigative Site 011
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Houston : Forest Investigative Site 027
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Houston : Forest Investigative Site 016
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Houston : Alain Katic, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Houston : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Houston : Bayou City Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Houston : Red Oak Psychiatry Associates, P.A.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Irving : University Hills Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Lake Jackson : R D Clinical Research
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Lake Jackson : R/D Clinical Research
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Plano : Forest Investigative Site 010
Safety and Efficacy of Vilazodone in Major Depressive Disorder
San Antonio : Univ of Texas Helath Science Center at San Antonio
12- Week Open Label Treatment of Refractory Bipolar Depression
San Antonio : Clinical Trials of Texas
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
San Antonio : Clinical Trials of Texas, Inc.
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
San Antonio : Clinical Trials of Texas, Inc
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Antonio : Clinical Trials of Texas, Inc.
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
San Antonio : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
San Antonio : Clinical Trials of Texas, Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Antonio : Forest Investigative Site 080 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
San Antonio : Call for Information (Investigational Site 0043)
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
San Antonio : Forest Investigative Site 002
Safety and Efficacy of Vilazodone in Major Depressive Disorder
San Antonio : Forest Investigative Site 016
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
San Antonio : Forest Investigative Site 020
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
San Antonio : Forest Investigative Site 034
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
The Woodlands :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Wharton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Wharton : Wharton Research Center, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wichita Falls : Grayline Clinical Drug Trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Wichita Falls : Grayline Clinical Drug Trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Wichita Falls : Grayline Clinical Drug Trials
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Wichita Falls : Grayline Clinical Drug Trials
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Wichita Falls : Grayline Clinical Drug Trials
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Witchita Falls : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Utah
Murray : Radiant Research - Salt Lake City
Clinical Research Study for Depression
Murray : Radiant Research - Salt Lake City
Depression Research Study
Murray : Radiant Research - Salt Lake City
Research Study for Depressiondep
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt Lake CIty : Lifetree Clinical Research
Depression
Salt Lake City : CRI Lifetree
This study is designed to evaluate the efficacy, safety, and tolerability of cariprazine
relative to placebo for the treatment of major depressive disorder as an adjunct to ADT
Salt Lake City : CRI Lifetree
To compare the change from baseline (Week 7 in Phase B) to endpoint (Week 13 in Phase C) in MADRS score of 2 fixed-doses of BMS-820836 (1 and 2 mg/day) versus continuation of the antidepressant treatment to which inadequate response has been prospectively demonstrated in subjects with TRD.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.
Salt Lake City : CRI Lifetree
To evaluate the efficacy of treatment with flexible doses of Lu AA21004 (10 or 20 mg QD) versus placebo on cognitive dysfunction in patients with MDD
Salt Lake City : CRI Lifetree
To evaluate the mean difference in Hamilton Depression Rating Scale 17 (HDRS-17) score for the combined GLYX 13 group mean change versus the placebo group mean change at the end of a 6 week randomized withdrawal phase (predose baseline score - score at end of randomized withdrawal period).
View More »
Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Clinton : Ericksen Research And Development
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinton : Ericksen Research and Development
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Clinton : Ericksen Research And Development
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Murray : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Murray : Radiant Research, Inc.
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Murray : Radiant Research, Inc.
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Murray : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Orem : Aspen Clinical Research
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Orem : Forest Investigative Site 030 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Orem :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Orem : Aspen Clinical Research, LLC
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Salt Lake City : Fatigue Consultation Clinic
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Salt Lake City : Lifetree Clinical Research, LC
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Salt Lake City : Lifetree Clinical Research
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Salt Lake City :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Salt Lake City : University of Utah
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Salt Lake City : Clinical Methods Llc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Salt Lake City :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Salt Lake City : Clinical Methods Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Salt Lake City : Psychiatric And Behavioral Solutions
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Salt Lake City : Forest Investigative Site 028 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Salt Lake City : Clinical Methods
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Vermont
Woodstock : Neuropsychiatric Associates
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Woodstock : Neuropsychiatric Associates
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Woodstock : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Virginia
Charlottesville : Charlottesville Medical Research
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Charlottesville : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Herndon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Herndon : Neuroscience, Inc
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Herndon : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
View More »
Richmond : Alliance Research Group
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Richmond : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Richmond : Alliance Research Group
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond : Virginia Commonwealth University
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond : Virginia Treatment Center for Children
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Richmond : Virginia Commonwealth University
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Richmond : Alliance Research Group
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Richmond : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Richmond : Alliance Research Group
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Roanoke : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Roanoke :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Washington
Bellevue : Northwest Clinical Research Center
Depression
Bellevue : Northwest Clinical Research Center
Depression & Menopause
Seattle : Summit Research Network (Seattle) LLC
Depression Research Study
Seattle : Summit Research Network (Seattle) LLC
Depression Research Study
View More »
Bellevue : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Bellevue : Research Site
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Bellevue : Alkermes Investigational Site
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Bellevue : Northwest Clinical Research Center
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Bellevue : Northwest Clinical Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Bellevue : Forest Investigative Site 032 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Bellevue : Forest Investigative Site 059
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Bellevue : Forest Investigative Site 006
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Bellevue : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Kirkland : Eastside Therapeutic Resource
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Kirkland : Eastside Therapeutic Resource
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Kirkland :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Kirkland : Forest Investigative Site 034 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Kirkland : Eastside Therapeutic Resource
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Richland : Scientella, LLC.
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Seattle : Summit Research Network (Seattle) LLC
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Seattle : Summit Research Network (Seattle) LLC
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Seattle : Forest Investigative Site 043 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Seattle :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Seattle :
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Seattle : Summit Research Network (Seattle) LLC
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Seattle :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Seattle : Summit Research Network (Seattle) Llc
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Seattle : Forest Investigative Site 013
Safety, Efficacy and Tolerability of Vilazodone in Major Depressive Disorder
Seattle : Forest Investigative Site 032
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Seattle : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Spokane : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Spokane : Forest Investigative Site 054
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Spokane : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Spokane : Frontier Institute
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Wisconsin
Brown Deer :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Brown Deer : Northbrooke Research Center
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brown Deer : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Brown Deer : Northbrooke Research Center
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Middleton : Dean Foundation for Health, Research & Education
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
View More »
Middleton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Middleton : Dean Foundation For Health Research & Education
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Middleton : Forest Investigative Site 052
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Middleton : Dean Foundation for Health, Research and Education, Inc.
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Middleton : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Milwaukee : Rogers Center for Research and Training, Incorporated
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Milwaukee : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Milwaukee : Rogers Center for Research and Training, Incorporated
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Milwaukee :
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
Milwaukee : Forest Investigative Site 056
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Waukesha : Forest Investigative Site 057 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Waukesha :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Waukesha : Independent Psychiatric Consultants, Sc, Dba, Ipc Research
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Waukesha : Independent Psychiatric Consultants, SC, dba, IPC Research
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Argentina
Buenos Aires : B.A. Psychiatric Research Cent
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Buenos Aires : INECO
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Buenos Aires : Dr. Gregorio Hugo Sorin
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Buenos Aires : Instituto FLENI
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Córdoba : Sanatorio Prof. León S. Morra SA
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
View More »
Rosario : Centro de Investigación y asistencia en Psiquiatria (CIAP)
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Australia
Adelaide : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brisbane : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Brisbane : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Everton Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Frankston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
View More »
Heidelberg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Heidelberg : AU004
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Heidelberg : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Malvern : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Malvern : Neurotherapy Victoria Clinical Trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Melbourne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Melbourne : The Alfred Hospital
International Study to Predict Optimised Treatment - in Depression
Melbourne : Swinburne University
International Study to Predict Optimised Treatment - in Depression
Melbourne : Monash Alfred Psychiatry Research Centre
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Melbourne : Northern Area Mental Health Services Northern Psychiatric R
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nedlands : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Nedlands : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Spring Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Sydney : The University of New South Wales/ Black Dog Institute
A Study of Omega-3 as a Treatment for Major Depression
Sydney : The University of New South Wales/Black Dog Institute
A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression
Westmead : Brain Dynamic Centre
International Study to Predict Optimised Treatment - in Depression
Austria
Innsbruck :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Neunkirchen : AT004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Vienna : AT003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Wien : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Wien : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Wien, Vienna :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Belgium
Brugge : BE001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Dave : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Diest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Duffel :
Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients
Heusden-Zolder : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
View More »
Kortenberg : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Lede : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Leuven :
Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Mont-Godinne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Sint-Niklaas : BE003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Bulgaria
Bourgas : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Bourgas : BG001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Bourgas : District Department of Psychiatric Disorders With Stationary
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pazardjik : State Psychiatric Hospital - Pazardjik
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pazardzhik : BG002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
View More »
Pleven : Forest Investigative Site 302
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Pleven : Psychiatric clinic for women UMHAT "Dr. Georgi Stranski"
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Plovdiv : Forest Investigative Site 301
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Plovdiv : ODPZS- EOOD, Plovdiv, Bulgaria
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Rousse : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Sofia : BG003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Sofia : BG005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Sofia : Forest Investigative Site 306
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Sofia : Psychiatric clinic, University Hospital "Alexandrovska"
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Sofia : MHAT Doverie
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Varna : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Varna : BG004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Varna : Diagnostic Consultative Center "Tchaika"
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Varna : MHAT - Sveta Marina
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Canada
Kelowna, BC : Okanagan Clinical Trials
Are you being treated for depression and experiencing sexual dysfunction as a result of your antidepressant medication?
View More »
Brampton : Dr. Naresh Aggarwal
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Burlington :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Chatham : Chatham-Kent Clinical Trials Research Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Chatham : CA008
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Chatham : Forest Investigative Site 101
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Edmonton : Grey Nuns Hospital
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gatineau :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Gatineau : Richard Bergeron, M.D.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Gatineau : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Hamilton : Women's Health Concerns Clinic
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
Hamilton : Women's Health Concerns Clinic
Duloxetine for Major Depression in Peri-/Postmenopausal Women
Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services
Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
Hamilton : McMaster University Medical Centre
Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
Kelowna : Forest Investigative Site 102
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Kentville :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Kingston :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Kingston : Providence Care Mental Health Services
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Kirkland : Merck Frosst Canada Ltd.
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM2)
London : Regional Mental Health Care
Aripiprazole and Resistant Postpartum Depression
Medicine Hat :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Medicine Hat : Forest Investigative Site 104
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Mississauga :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Mississauga : Anxiety and Mood Disorder Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Mississauga : Medical Research Associates
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Montreal : Centre de Recherche Fernand-Seguin
Effect of Antidepressants on White Matter Structure
Montreal : CA001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Montreal : Centre de Recherche Fernand Seguin
Inflammatory Markers and Cognitive Function in Major Depression
Montreal : Hôpital Louis Hlafontaine
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Montreal : Immunodeficiency Service Montreal Chest Institute McGill University Health Centre
Trial of Citalopram for the Prevention of Depression
Montréal : Douglas Mental Health University Institute
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
Oakville : Satpal Girgla M.D.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Oakville : CA007
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Ottowa :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Parry Sound : International Sleep Clinic, West Parry Sound Health Centre
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Penticton : Dr. Alexander McIntyre Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Penticton :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Penticton : Alexander McIntyre, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Penticton : Forest Investigative Site 103
Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Penticton : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Penticton : Dr. Alexander McIntyre, Inc.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Pointe-Claire : Kells Medical Research Group Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Quebec : ALPHA Recherche Clinique
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sherbrooke : Diex Research Sherbrooke Inc.
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Sherbrooke :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Sherbrooke : Q&T Research Sherbrooke
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sydney :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Thornhill : Canadian Centre for Clinical Trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Toronto : University Health Network - Toronto General Division
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Toronto : University Health Network - Toronto Western Division
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Toronto :
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
Toronto : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Toronto : Manna Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Martin Katzman, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : Sleep & Alertness Clinic (Sleep & Alertness Research, Inc.)
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Toronto : CA002
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Toronto : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Vancouver : Dr. D. McIntosh & Dr. K. Kjernisted Clinical Research Inc.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Vancouver : CA006
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Vancouver : University of British Columbia, Department of Psychiatry
Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
Vancouver : Institute of Mental Health, University of British Columbia
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
Chile
Antofagasta : Luis Alberto Barra Ahumada, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Las Condes : Dr. Claudia Carolina Barrera Renault
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Las Condes : Guillermo Antonio Vergara Harris, MD
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Providencia : Sergio Moises Gloger Kojchen
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Miguel : Dr. Marcela Eugenia Rojas Segura
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Santiago :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Santiago : Jaime Marvele Solis Gonzalez
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Santiago : Manuel Jesus Sebastian Lavados Montes
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
China
Baoding : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Beijing : CN001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Changsha : The Second Xiangya Hospital of Central South University
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Guang Zhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
View More »
Hangzhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Harbin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Kunming : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Nanjing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Shanghai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Xi'An : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Croatia
Rab : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Rijeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Split : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
View More »
Zagreb : Psychiatric Hospital Vrapce
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Czech Republic
Brno : CZ012
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Brno : CZ003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Brno : Jan Holan, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Brno : Michaela Klabusayova, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Horovice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
View More »
Horovice : Oto Markovic, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Hostivice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Kladno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Kutna Hora : Psychiatrie s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Litomerice : Bialbi s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Olomouc : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Olomouc : CZ005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Prague 10 : Clintrial s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prague 5 : Psychiatry Trial s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Prague 6 : Prague Medical Services s.r.o.
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Praha : CZ004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Praha : CZ006
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Praha 1 : CZ009
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Praha 10 : CZ008
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Praha 6 : CZ002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Praha 9 : CZ010
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Ricany : Jan Cernak, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Strakonice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Usti Nad Labem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Denmark
Roskilde : The day clinic for treatment of non-psychotic disorders (Roskilde Psychiatry)
Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial
Estonia
Parnu : EE003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tallinn : EE001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tallinn : EE005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tallinn : Forest Investigative Site 203 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Tallinn : Forest Investigative Site 206 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
View More »
Tallinn : Forest Investigative Site 201 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Tallinn : Forest Investigative Site 205 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Tartu : EE002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tartu : EE004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tartu : Forest Investigative Site 207 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Tartu : Forest Investigative Site 204 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Tartu : Forest Investigative Site 208 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Võru : Forest Investigative Site 202 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Finland
Helsinki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Helsinki : FI004
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Helsinki : FI002
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Helsinki : FI008
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Helsinki : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
View More »
Helsinki : Forest Investigative Site 304 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Helsinki : Forest Investigative Site 301 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Helsinki : Forest Investigative Site 302 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Helsinki : Forest Investigative Site 306 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Helsinki : FF Servies OY/ FF Reseach
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Helsinki : Helsingin kaupunki, Auroran sairaala
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Jarvenpaa : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Joensuu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Jyväskylä : Forest Investigative Site 303 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Kangasala : Kaivannon sairaala
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Kuopio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Kuopio : FI001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Kuopio : Forest Investigative Site 305 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Lohja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Oulu : FI009
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Oulu : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Oulu : Forest Investigative Site 308 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Pori : Forest Investigative Site 307 Updated
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Rauma : FI006
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Seinajoki : FI003
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Tampere : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Tampere : FI005
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Tampere : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Turku : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Turku : Turun psykiatripalvelu
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
France
Arcachon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Arcachon : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Besancon : CHU Besancon - Clinical Psychaitric Department
Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression
Besançon : C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Bron : C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
View More »
Caen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Caen : FR003
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Clermont Ferrand : C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Colombes : Hôpital Louis Mourier
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Dijon : C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Dijon Cedex : FR008
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Dole : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Dole : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Dole : CMP/CHS du Jura
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Douai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Douai : FR006
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Douai : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Elancourt : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Elancourt : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Elancourt : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Fains : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Grenoble : C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Jonzac : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Jonzac : Centre Hospitalier de Jonzac
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Lézignan-Corbières : ASM Limoux
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Lille : Hôpital Fontan - C.H.R.U. Lille
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Limoges Cedex : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Marseille : C.H. Sainte Marguerite
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Montpellier : CHU - Hôpital La Colombière
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Montpellier Cedex 5 : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Nice : CHU Pasteur
European Deep Brain Stimulation (DBS) Depression Study
Nice : Hôpital Pasteur - CHU Nice
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Nîmes : Hopital Universitaire Caremeau-Batiment Polyvalent, Service
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Orvault : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Palaiseau : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Paris : FR
A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder
Paris : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Paris : Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Poitiers : C.H.U. de POITIERS
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Rennes : C.H.U. - C.H. Guillaume Régnier
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Rouen : C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Saint-Denis : EPS de Ville Evrard - Unité de Saint-Denis
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
St Etienne cedex : CHU St Etienne - Hôpital Nord
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Toulon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Toulouse : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Toulouse : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Tours : CPU CHRU de Tours
BDNF Gene Polymorphism and Antidepressants Treatment
Germany
Achim : Andreas Mahler, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Achim : DE007
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Achim : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Achim : Praxis Dr. Andreas Mahler
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Bad Saarow : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
View More »
Baesweiler : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Berlin : DE005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Berlin : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Berlin : Jana Thomsen, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin : Alexander Schulze, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin : emovis GmbH
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Berlin : DE005
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Berlin :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Berlin : Charité - Universitätsmedizin Berlin
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Bochum : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Bochum : Ralf Bitter, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bonn : University Clinic Bonn
The Effect of Duloxetine on Interoceptive Awareness
Butzbach : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Cham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Cologne : University of Cologne
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Dortmund : Research Site
European Drug Utilization Study
Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Dresden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Dresden : Universitatsklinikum Carl Gustav Carus
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Düsseldorf : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Erfurt : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Essen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Freiburg : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Freiburg :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Freiburg : University of Freiburg
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gelsenkirchen : DE004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Göttingen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Hamburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Hannover : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Hattingen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Heidelberg : DE003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Ingolstadt : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Kandel : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Leipzig : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Leipzig : DE001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Leipzig : Marion Schnabel, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Ludwigshafen : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Mainz : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Mainz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Mannheim :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Marburg : Department of Clinical Psychology and Psychotherapy, Philipps University Marburg
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Mittweida : Pharmakologisches Studienzentrum Chemnitz GmbH, Außenstelle
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Muenchen : Studienzentrum Muenchen
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Munich : Department of Psychiatry and Clin. Radiology, Ludwig-Maximilian-University
Somatosensory Processing in Depression
Nuernbeg : Isabel Hach, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nurnberg : DE009
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Nürnberg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Nürnberg :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Oranienburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Ostfildern :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Prien : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Schönau am Königssee : Klinikum Berchtesgadener Land, Schön Kliniken
End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Schwerin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Schwerin : Somni bene GmbH
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Schwerin, Mecklenburg-vorpomme :
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Stralsund : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Wermsdorf : Novartis Investigative Site
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Westerstede : Studiezentrum Nord-West
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wuerzburg : Medizinisches Studienzentrum Wuerzburg
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Wurzburg : DE001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Wurzburg : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Greece
Haidari : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Thessaloniki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Tripoli : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Hungary
Baja : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Baja N/A : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Budapest : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Budapest : Istvan Bitter
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Budapest : Research Site
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
View More »
Budapest : Semmelweis University, Psychiatric Clinic
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Budapest : Obudai Egeszsegugyi Centurm Kft.
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Budapest : Forras Outpatient Clinic
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Budapest : Varoskapu Outpatient Clinic
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gyor : Petz Aladar Megyei Oktatokorhaz Pszichiatriai Osztaly
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Kalocsa : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Nagyerkei : Ede Frecska, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nagykalio : Csilia Varga, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nagykallo : Santha Kalman Szakkkorhaz
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Nyfregyhaza : Alexander Kancsev, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
India
Ahmedabad : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Varanasi : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Israel
Hod Hasharon : shalvataMHC
Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression
Jerusalem : Hadassah-Hebrew University Medical Center
European Deep Brain Stimulation (DBS) Depression Study
Tel Hashomer : Sheba Medical Center, Department of psychiatry
Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
Italy
Camaiore-Viareggio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Catania : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Catania : Azienda Ospedaliero Univ. Policlinico - Vittorio Emanuele
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Colleferro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Ferrara : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
View More »
Firenze : S.O.D. of Psychiatry, A.O.U. Careggi
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Genova : Clinica Psichiatrica (Pad. A), A.O. Ospedale San Martino
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Milan : IT001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Pisa : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Pisa : Centro per i disturbi del sonno
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Roma : Ospedale Sant'Andrea,Servizio Psichiatrico di Diagnosi e Cur
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Siena : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Turin : IT002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Japan
Adachi-ku : Suzuki Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Adachi-ku : Suzuki Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Amagasaki : Arai Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Amagasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Anan-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
View More »
Annaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Ashiya : Terauchi-Takahashi Psychiatric Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Ashiya : Terauchi-Takahashi Psychiatric Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Chiyoda-ku : Iidabashi Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Chubu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Chugoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Chuo-ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Fujioka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fujisawa-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukaya-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Fukuoka : Stress Care Yoshimura Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Tenjin Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Kuranari Psychiatry Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukuoka : Imato Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Medical Corporation Shinseikai Kaku Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Tenjin Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Stress Care Yoshimura Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Sugahara Tenjin Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Akasaka Kato Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Ange Psychiatric Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Hiro Mental Clinic Tenjinminami
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka : Kuranari Psychiatry Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka-city :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Fukuoka-city : Hatsuki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Fukuoka-shi : Stress Care Yoshimura Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Hachioji-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hatsukaichi : Fujikawa Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Hatsukaichi : Fujikawa Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Hatsukaichi-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hirakata : Kuginuki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Hiroshima : Tsuji Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Hiroshima-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Hokkaido :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Hokkaido :
Long-term Study of FK949E in Elderly Bipolar Disorder Patients
Hokkaido :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Hokkaidou :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Ibaraki :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Inzai : Nippon Medical School Chiba Hokusoh Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Inzai : Nippon Medical School Chiba Hokusoh Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Inzai-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Kanagawa :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kanagawa : Medical Corporation Toyokokai Tawara Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kanazawa : National Hospital Organization Kanazawa Medical Center
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kanazawa : National Hospital Organization Kanazawa Medical Center
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kansai :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Kanto :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Kantou :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Katsushika-ku :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Katsushika-ku : Fuku Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kawasaki : Kishiro Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kawasaki : Kishiro Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kawasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kinki :
Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients
Kita-ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kitakyushu-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kobe : Ikeuchi Psycho Induced Internal Med.Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kobe : Ikeuchi Psycho Induced Internal Med.Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kobe : Tatsuta Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kobe-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kumamoto-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kumamoto-shi : Yuge Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kurashiki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kurayoshi-shi :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Kure : Hayakawa Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kyoto : Sagaarashiyama-Tanaka Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Kyoto : Sagaarashiyama-Tanaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Kyoto-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Kyushu :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Minato-ku : Akasaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Minato-ku : SAKURAZAKA CLINIC SophyAnce
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Musashino-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Nagareyama : Hida Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nagoya : Mizuho Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nagoya : Narumi Himawari Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nakano-Ku : Harikae mental clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nakano-ku : Heartcare Ginga Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Nanyo-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Nara : Kyo Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Noda City : Nakamoto Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Noda City : Nakamoto Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Noda-City :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Omuta : Shiranui Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Omuta : Shiranui Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Omuta-city : Oka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Osakasayama-shi : Shibamoto Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Osaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Osaka-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Sagamihara : Yutaka Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Sagamihara : Yutaka Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Sagamihara-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saitama : Misato Ekimae Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Saitama-city :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Saitama-city : Sakai Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Sapporo-Shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Sapporo-Shi : Kawamura Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Setagaya-ku : Sangenjaya Nakamura Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Setagaya-ku : Sangenjaya Nakamura Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Setagaya-ku : Komazawa Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuyaku : Yoyoginomori Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuya-ku : Maynds Tower Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Shibuya-ku : Omotesando Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shibuya-ku : Maynds Tower Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shikoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Shinagawa-Ku : Himeno Tomomi Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinagawa-ku : Meguro sta.East Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Shinjuku-ku : Tokyo Kosei Nenkin Hospital
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Nishi-Shinjuku Concieria Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Tokyo Kosei Nenkin Hospital
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Kagurazaka Stress Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Shinjuku-ku : Tamaki Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Taito-Ku : Local Institution
Japanese Phase 1 Multiple Ascending Dose (MAD) Study
Takasaki-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tokushisma-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY221668412 in Patients With Major Depression Disorder
Tokyo :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Tokyo :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tokyo : Omotesando Mental Clinic 9F Success Aoyama
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Tokyo : Eto Mental Clinic Meguro
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Toshima-ku : Himorogi Psychiatric Institute
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Toshima-ku : Himorogi Psychiatric Institute
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Touhoku :
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Utsunomiya-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Yokohama : Tawara Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Yokohama : Medical Coporation Toyokokai Tawara Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Yokohama-shi :
Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
Yokohama-Shi : Azamino Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Yokosuka city : Shioiri Mental Clinic
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Yokosuka city : Shioiri Mental Clinic
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Korea, Republic of
Ansan : 03
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Ansan : Korea University Ansan Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Anyang : 19
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Anyang : Hallym Univesity Sacred Heart Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Bucheon : KR005
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
View More »
Busan : 26
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Busan : 08
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Busan : Dong-A University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Chungbuk : 23
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : 04
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : 05
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Daegu : Dongsan Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Daejeon : Chungnam National University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Daejon : 16
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Goyang : 28
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Goyang : Dongguk University International Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Guri : Hanyang University Guri Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Gwangju : Chonnam National University Hospital
Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
Gwangju : 29
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gwangju : 24
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gwangju : Chosun University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Gyeonggi-Do : 11
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Inchon : Inha University Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Jinju : 15
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Kangnam : Samsung Medical Center
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Seoul : Seoul National University Hospital
Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Seoul : Seoul National University Hospital
Lexapro®'s Efficacy After Dose Escalation in Remission Study
Seoul : Seoul National University Hospital
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Seoul : Seoul St. Mary's Hospital
Quality of Life and Depression in Dialysis Patients
Seoul : 13
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 14
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 18
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 20
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 21
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 06
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 07
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 09
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 27
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 01
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 02
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 17
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 22
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 10
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : 12
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Seoul : KR001
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR006
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR007
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR002
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : KR003
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Seoul : Konkuk Univ. Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : Asan Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : KyungHee University Medical Center
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Seoul : Severance Hospital
The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
Sungnam : KR004
Study of Lu AA21004 in Major Depressive Disorder in Asian Countries
Yangsan : 25
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Latvia
Daugavpils : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Daugavpils : LV006
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Jelgava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Jelgava : LV002
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Liepaja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
View More »
Liepaja : LV004
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Riga : LV003
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Sigulda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Sigulda : LV005
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Strenci : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Strenci : LV001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Lithuania
Kaunas : LT001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Kaunas : LT003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Klaipeda : LT004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Palanga : LT006
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Vilnius : LT005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
View More »
Vilnius : LT002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Mexico
Aguascalientes :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Leon Gto : MX001
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Leon Guanajuato : Juan Luis Vazquez-Hernandez
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
León, Guanajuato :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Mazatlan : MX003
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
View More »
Monterrey : MX005
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Monterrey :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Nuevo Leon : Jose Alfonso Ontiveros, MD
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Nuevo Leon : Omar Kawas Valle
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Sinaloa : Gabriel Bernal Gamboa
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Monaco
Monaco : Centre Hospitalier Princesse Grace
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Netherlands
Nijmegen : Brainclinics Diagnostics B.V.
International Study to Predict Optimised Treatment - in Depression
New Zealand
Auckland : University of Auckland
International Study to Predict Optimised Treatment - in Depression
Norway
Lorenskog : Akershus University Hospital
Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
Philippines
Manila : Private Clinic
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
Poland
?Uromin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Bialystok : Prywatne Gabinety Lekarskie "Promedicus"
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bialystok :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Bydgoszcz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
View More »
Bydgoszcz : Professor Aleksander Araszkiewicz
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bydgoszcz : Szpital Uniwersytecki im.dr.A.Jurasza w Bydgoszczy
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Chelmno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Chelmno : Zespol Opieki Zdrowotnej w Chelmnie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Choroszcz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Gdansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Gdansk : PL001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Gdansk : Updated
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Gdansk : Wojewodzki Szpital Psychiatryczny im. prof. Tadeusza Bilikie
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gdansk : Klinika Chorob Psychicznych i Zaburzen Nerwicowych GUM
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Gdynia : PL002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Gdynia :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Gdynia : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Gorlice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Gorlice : PL008
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Gorlice : Centrum Psychiatrii i Psychoterapli
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Katowice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Katowice : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Kielce : NZOZ Syntonia, Poradnia Zdrowia Psychicznego
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Krakow : Malopolskie Centrum Medyczne
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Leszno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lodz :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Lublin : PL006
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Lublin : PL007
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Lublin : Osrodek Badafi Klinicznych Prof dr hab n med Meszek Szczepanski Prywatna Praktyka Lekarska
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Lublin : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Skorzewo : PL003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Torun : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Torun : PL005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Torun :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tuszyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Tuszyn : PL010
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Tuszyn :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Tuszyn : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Warszawa : Research Site
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Zuromin : Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej w Zurominie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Puerto Rico
Corozal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Ponce : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Ponce : Local Institution
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
Ponce : Local Institution
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
View More »
San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
San Juan : Forest Investigative Site 033 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
San Juan : Forest Investigative Site 034 Updated
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
San Juan : INSPIRA Clinical Research
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
San Juan : Dharma Institute & Research Center
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Romania
Arad : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Arad : RO005
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Arad : Spitatul Clinic Judetean de Urgenta Arad, Clinica de Psihiatrie
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Botosani : Stefi-Dent SRL
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Bucaresti : Spitalui Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia" Sectia Clinica Psihiatrie I
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
View More »
Bucharest : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Bucharest : RO002
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Bucharest : RO003
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Bucharest : RO004
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Bucuresti :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Constanta :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Craiova : RO001
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Craiova :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Focsani : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Focsani : RO007
A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Iasi : Updated
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Oradea : Crucea Alba
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Targouiste :
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Targoviste : Lorentina 2201 SRL
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Targu Mures : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Prevention of Re-emergence of Depression Symptoms
Targu Mures : Spitalul Clinic Judetean Mures
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder